We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.
Biodegradation of MTBE and BTEX in an aerobic fluidized bed reactor.
An aerobic fluidized bed reactor (FBR) was operated for the removal of methyl tert-butyl (MBE) and benzene, toluene, ethylbenzene, and p-xylene (BTEX) from water. The reactor was seeded with a mixed culture adapted to MTBE. Granular activated carbon (GAC) was used as the biological attachment medium. Influent MTBE to the reactor was 7.8 mg/L MTBE, with a flow rate of 22.7 L/day, and an empty bed contact time of 1 hour. The acclimation period required was relatively short, about 30 days before reaching an average stable effluent concentration of 18.5 +/- 10 microg/L. BTEX was introduced to the feed at an equivalent chemical oxygen demand (COD) as the MTBE at day 225 and was biodegraded spontaneously with no apparent acclimation period required. The average influent of each of the four BTEX compounds was about 2 mg/L, and the range of the average effluent concentrations wae 1.4-2.2 microg/L. After achieving 180 days of stable performance with BTEX addition, the total low rate to the reactor was gradually increased by 20% increments to 160% of the original flow (36.4 L/day). Increases by 20% and 40% had no apparent effect on reactor performance, but increase by 60% required 30 days before effluent quality returned to previous values. Composition of the culture was monitored throughout operation of the reactor using denaturing gradient gel electrophoresis (DGGE). The culture consisted of Flavobacteria-Cytophaga and organisms with high similarity to the known MTBE degrader PM1.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app